16.11
price down icon2.33%   -0.385
 
loading
Precedente Chiudi:
$16.50
Aprire:
$16.72
Volume 24 ore:
559.94K
Relative Volume:
0.69
Capitalizzazione di mercato:
$1.36B
Reddito:
$17.49M
Utile/perdita netta:
$-78.50M
Rapporto P/E:
-13.43
EPS:
-1.2
Flusso di cassa netto:
$-52.85M
1 W Prestazione:
-0.52%
1M Prestazione:
+18.32%
6M Prestazione:
+61.47%
1 anno Prestazione:
+13.05%
Intervallo 1D:
Value
$16.10
$16.74
Intervallo di 1 settimana:
Value
$16.10
$16.81
Portata 52W:
Value
$8.26
$16.99

Liquidia Corp Stock (LQDA) Company Profile

Name
Nome
Liquidia Corp
Name
Telefono
919.328.4400
Name
Indirizzo
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
Dipendente
145
Name
Cinguettio
@Liquidia_Inc
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
LQDA's Discussions on Twitter

Confronta LQDA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LQDA
Liquidia Corp
16.11 1.36B 17.49M -78.50M -52.85M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-20 Iniziato Wells Fargo Overweight
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-08-19 Aggiornamento Raymond James Outperform → Strong Buy
2024-08-16 Iniziato Raymond James Outperform
2024-06-25 Iniziato Oppenheimer Perform
2024-01-05 Reiterato Needham Buy
2022-09-19 Ripresa Wedbush Underperform
2022-09-01 Downgrade Wedbush Neutral → Underperform
2022-07-22 Iniziato Ladenburg Thalmann Buy
2022-05-31 Iniziato BTIG Research Buy
2022-05-26 Iniziato BofA Securities Buy
2020-12-04 Iniziato H.C. Wainwright Buy
2020-11-20 Downgrade Wedbush Outperform → Neutral
2018-11-08 Ripresa Jefferies Buy
2018-09-05 Iniziato Wedbush Outperform
2018-08-20 Iniziato Jefferies Buy
2018-08-20 Iniziato Needham Buy
Mostra tutto

Liquidia Corp Borsa (LQDA) Ultime notizie

pulisher
Feb 12, 2025

Bleakley Financial Group LLC Lowers Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

The Attractiveness of Investing In Liquidia Corp (LQDA) is Growing - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Liquidia Co. (NASDAQ:LQDA) Receives $25.38 Average Price Target from Brokerages - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Liquidia Corp's chief business officer sells $6,319 in stock - MSN

Feb 08, 2025
pulisher
Feb 07, 2025

Life Sciences Group Of The Year: Cooley - Law360

Feb 07, 2025
pulisher
Feb 06, 2025

Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex

Feb 06, 2025
pulisher
Feb 06, 2025

Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

Liquidia Corp (LQDA) stock on the rise: An overview - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily

Feb 04, 2025
pulisher
Jan 31, 2025

Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha

Jan 31, 2025
pulisher
Jan 25, 2025

Liquidia Corp's chief medical officer sells $31,785 in stock - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Liquidia Co. (NASDAQ:LQDA) Insider Sells $31,785.00 in Stock - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Liquidia Corp's chief medical officer sells $31,785 in stock By Investing.com - Investing.com UK

Jan 23, 2025
pulisher
Jan 22, 2025

Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? - Yahoo Finance

Jan 22, 2025
pulisher
Jan 15, 2025

Barclays PLC Purchases 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

Rajeev Saggar Sells 6,249 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Roger Jeffs Sells 22,343 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 16,393 Shares - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia’s chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Nigeria

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp chief business officer sells $56,650 in stock By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief commercial officer sells shares worth $98,504 - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp general counsel sells shares worth $193,109 - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp chief business officer sells $56,650 in stock - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Liquidia Corp general counsel sells shares worth $193,109 By Investing.com - Investing.com UK

Jan 14, 2025
pulisher
Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 12, 2025

Liquidia’s (LQDA) Buy Rating Reiterated at Needham & Company LLC - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $25.38 - MarketBeat

Jan 11, 2025
pulisher
Jan 09, 2025

Liquidia's (LQDA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga

Jan 09, 2025
pulisher
Jan 08, 2025

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Jan 08, 2025
pulisher
Jan 08, 2025

Liquidia CEO to Present at J.P. Morgan Healthcare Conference 2025 in San Francisco - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

Yutrepia's Launch: A Catalyst for Liquidia (LQDA) - substack.com

Jan 07, 2025
pulisher
Jan 01, 2025

Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Barclays PLC Buys 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Barclays PLC Boosts Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World

Dec 31, 2024
pulisher
Dec 27, 2024

Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know - Insider Monkey

Dec 27, 2024
pulisher
Dec 24, 2024

State Street Corp Decreases Stock Holdings in Liquidia Co. (NASDAQ:LQDA) - Defense World

Dec 24, 2024
pulisher
Dec 24, 2024

State Street Corp Has $21.75 Million Holdings in Liquidia Co. (NASDAQ:LQDA) - MarketBeat

Dec 24, 2024
pulisher
Dec 23, 2024

Liquidia (NASDAQ:LQDA) Research Coverage Started at Wells Fargo & Company - Defense World

Dec 23, 2024
pulisher
Dec 20, 2024

Wells Fargo & Company Initiates Coverage on Liquidia (NASDAQ:LQDA) - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $833,000 Stake in Liquidia Co. (NASDAQ:LQDA) - Defense World

Dec 20, 2024

Liquidia Corp Azioni (LQDA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Liquidia Corp Azioni (LQDA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Saggar Rajeev
Chief Medical Officer
Jan 21 '25
Sale
13.00
2,445
31,785
267,943
Schundler Russell
General Counsel
Jan 14 '25
Sale
11.78
16,393
193,110
573,478
Saggar Rajeev
Chief Medical Officer
Jan 14 '25
Sale
11.78
6,249
73,613
270,388
Moomaw Scott
Chief Commercial Officer
Jan 14 '25
Sale
11.78
8,362
98,504
215,494
Kaseta Michael
CFO and COO
Jan 14 '25
Sale
11.78
23,370
275,299
401,755
Adair Jason
Chief Business Officer
Jan 14 '25
Sale
11.78
4,809
56,650
180,215
JEFFS ROGER
Chief Executive Officer
Jan 14 '25
Sale
11.78
22,343
263,201
1,019,177
Moomaw Scott
Chief Commercial Officer
Dec 02 '24
Sale
11.51
546
6,284
154,127
Kaseta Michael
CFO and COO
Dec 02 '24
Sale
11.51
1,091
12,557
312,328
Schundler Russell
General Counsel
Dec 02 '24
Sale
11.51
1,063
12,235
487,328
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Capitalizzazione:     |  Volume (24 ore):